LambdaVision raises $7M seed funding, co-led by Seven Seven Six and Aurelia Foundry Fund, to advance development of its artificial retina for patients with retinal diseases.
Amount Raised
$7 Million
Round Type
Seed
Investors
Description
LambdaVision has closed a $7 million seed funding round to manufacture its investigational protein-based artificial retina. The funding will support preclinical development and scale up space-enabled manufacturing. With support from Seven Seven Six and Aurelia Foundry Fund, it aims to bring the product closer to clinical trials. LambdaVision utilizes microgravity environments to enhance production quality.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as LambdaVision that raised within 45 days of this round, from Fundz verified event records.
- Lumov raised $1.2M (Seed) on December 8, 2025.
- Virax Biolabs raised $5M (Post-IPO Equity) on December 3, 2025.
- Lyric Bio raised $6.6M (Seed) on December 2, 2025.
- Xeltis raised $58M (Funding Round) on December 2, 2025.
- Morphocell Technologies raised $50M (Series A) on December 1, 2025.
- SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.
Who to call at LambdaVision, and when
A new round usually means LambdaVision is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LambdaVision raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LambdaVision, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LambdaVision. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LambdaVision raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
LambdaVision raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.